Epidemiology of Hypertension

Hypertension

Volumn , Issue , 2005, Pages 16-28

  Wong, Nathan D ^a   Franklin, Stanley S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 41449092238     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0258-5.50093-4     Document Type: Chapter

References (49)

1. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 2003, 289:2560-2572.
2. The WHO Monica Project: Risk factors. Int J Epidemiol 1989, 18:S46-S55.
3. Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003, 289:2363-2369.
4. Hajjar I, Kotchen TA Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003, 290:199-206.
5. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and women: The Framingham Heart Study. JAMA 2002, 287:1003-1010.
6. Keys A Seven Countries: A Multivariate Analysis of Death and Coronary Heart Disease 1980, Harvard University Press, Cambridge, MA.
7. Stamler J, Stamler R, Neaton JD Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med 1993, 153:598-615.
8. McMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease: Part 1. Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias. Lancet 1990, 335:765-774.
9. Kannel WB, Dawber TR, Kahan A, et al. Factors of risk in development of coronary heart disease: Six year follow-up experience-The Framingham Study. Ann Intern Med 1961, 55:33-50.
10. Kannel WB, Gordon T, Schwartz MR Systolic versus diastolic blood pressure and risk of coronary heart disease: The Framingham Study. Am J Cardiol 1971, 27:335-345.
11. Vasan RS, Larson MG, Leip EP, et al. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study. Lancet 2001, 358:1682-1686.
12. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001, 345:1291-1297.
13. Kotchen TA, Kotchen JM Regional variation in blood pressure: Environment or genes?. Circulation 1997, 96:1071-1073.
14. Kannel WB, Wilson PWF Cardiovascular risk factors and hypertension. Hypertension Primer, 3rd ed 2003, TX, American Heart Association, Dallas. J.L. Izzo, H.R. Black (Eds.).
15. McMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease: Part 1. Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias. Lancet 1990, 335:765-774.
16. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality. Lancet 2002, 287:1003-1010.
17. Levy D Left ventricular hypertrophy risk. Hypertension Primer, 3rd ed 2003, TX, American Heart Association, Dallas. J.L. Izzo, H.R. Black (Eds.).
18. Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990, 322:1561-1566.
19. Matthew J, Sleight P, Lonn E, et al. for the Heart Outcomes Prevention Evaluation (HOPE) Investigators. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypotrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 2001, 102:1615-1621.
20. Wolf PA Cerebrovascular risk. Hypertension Primer, 3rd ed 2003, TX, American Heart Association, Dallas. J.L. Izzo, H.R. Black (Eds.).
21. Kannel WB, McGree DL Update on some epidemiologic features of intermittent claudication: The Framingham Study. J Am Geriatr Soc 1985, 33:13-18.
22. Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996, 334:13-18.
23. Franklin SS Aging and hypertension: The assessment of blood pressure indices in predicting coronary heart disease. J Hypertension 1999, 17(Suppl 5):S29-S36.
24. Franklin SS, Jacobs MJ, Wong ND, et al. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives-Analysis based on NHANES III. Hypertension 2001, 37:869-874.
25. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995, 25:305-313.
26. Franklin SS, Gustin W, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure: The Framingham Heart Study. Circulation 1997, 96:308-315.
27. Neaton D, Wentworth JD Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Arch Intern Med 1992, 152:56-64.
28. Perry HM, Miller JP, Fornoff JR, et al. Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension 1995, 25(4 Pt 1):587-594.
29. Nielsen WB, Vestbo J, Jensen GR Isolated systolic hypertension: A significant risk factor of cerebral apoplexy and acute myocardial infarction. A prospective population based study. Ugeskr Laeger 1996, 158:3779-3783.
30. Kannel WB Risk stratification in hypertension: New insights from the Framingham Study. Am J Hypertens 2000, 13(1 Pt 2):3S-10S.
31. Franklin SS, Khan SA, Wong ND, et al. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999, 100:354-360.
32. Wong ND, Sciammarella M, Arad Y, et al. Relation of thoracic aortic and aortic valve calcium to coronary artery calcium and risk assessment. Am J Cardiol 2003, 92:951-955.
33. Benetos A, Safar M, Rudnichi A, et al. Pulse pressure: A predictor of long-term cardiovascular mortality in a French male population. Hypertension 1997, 30:1410-1415.
34. Verdecchia P, Schillaci G, Borgione C, et al. Ambulatory pulse pressure: A potent predictor of total cardiovascular risk in hypertension. Hypertension 1998, 32:983-988.
35. Staessen JA, Gasowski, Wang JG, et al. Risks of untreated and treated isolated systolic hypertension in the elderly metaanalysis of outcome trials. Lancet 2000, 104:865-872.
36. Dart AM, Kingwell BA Pulse pressure-A review of mechanisms and clinical relevance. J Am Coll Cardiol 2001, 37:975-984.
37. Van Bortel LMAB, Struijker-Boudier HAJ, Safar ME Pulse pressure, arterial stiffness, and drug treatment of hypertension. Hypertension 2001, 38:914-921.
38. Franklin SS, Larson MG, Khan SA, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 2001, 103:1245-1249.
39. Guidelines Committee 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003, 21:1011-1053.
40. Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993, 16:434-444.
41. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
42. Wong ND, Pio J, Franklin SS, et al. Preventing heart disease by nominal and optimal control of blood pressure and lipids in persons with the metabolic syndrome. Am J Cardiol 2003, 91:1421-1426.
43. Ford ES, Giles WH, Dietz WH Prevalence of the metabolic syndrome among US adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359.
44. Wong ND, Thakral G, Franklin SS, et al. Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and gender. Am Heart J 2003, 145(5):888-895.
45. Sytkowski PA, D'Agostino RB, Belanger AJ, et al. Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. Circulation 1996, 93:697-703.
46. Ogden LG, He J, Lydick E, et al. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension 2000, 35:539-543.
47. Wilson PWF, Smith SC, Blumenthal RS, et al. 34th Bethesda Conference: Task force #4-How do we select patients for atherosclerosis imaging?. J Am Coll Cardiol 2003, 41:1898-1906.
48. Cuspidi C, Ambrosioni E, Mancia G, et al. Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: The assessment of prognostic risk observational survey. J Hypertens 2002, 20:1307-1314.
49. Pearson TA Primary prevention. Preventive Cardiology 2000, Mc-Graw Hill, New York. N.D. Wong, H.R. Black, J.M. Gardin (Eds.).